FR2314197B1 - - Google Patents

Info

Publication number
FR2314197B1
FR2314197B1 FR7617698A FR7617698A FR2314197B1 FR 2314197 B1 FR2314197 B1 FR 2314197B1 FR 7617698 A FR7617698 A FR 7617698A FR 7617698 A FR7617698 A FR 7617698A FR 2314197 B1 FR2314197 B1 FR 2314197B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7617698A
Other languages
French (fr)
Other versions
FR2314197A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2314197A1 publication Critical patent/FR2314197A1/fr
Application granted granted Critical
Publication of FR2314197B1 publication Critical patent/FR2314197B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7617698A 1975-06-11 1976-06-11 Procede de preparation d'oxo-20 steroides insatures en 9,11 Granted FR2314197A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2526373A DE2526373C2 (de) 1975-06-11 1975-06-11 Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑-5α-20-Ketosteroiden

Publications (2)

Publication Number Publication Date
FR2314197A1 FR2314197A1 (fr) 1977-01-07
FR2314197B1 true FR2314197B1 (OSRAM) 1981-03-20

Family

ID=5948981

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7617698A Granted FR2314197A1 (fr) 1975-06-11 1976-06-11 Procede de preparation d'oxo-20 steroides insatures en 9,11

Country Status (10)

Country Link
US (1) US4061661A (OSRAM)
JP (1) JPS51149260A (OSRAM)
CH (1) CH620452A5 (OSRAM)
DD (1) DD125699A5 (OSRAM)
DE (1) DE2526373C2 (OSRAM)
DK (1) DK137837C (OSRAM)
FR (1) FR2314197A1 (OSRAM)
GB (1) GB1554901A (OSRAM)
HU (1) HU174227B (OSRAM)
NL (1) NL7606137A (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748442C3 (de) * 1977-10-26 1981-08-27 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17α-(3-Jodbenzoyloxy)-9α -chlor4-pregnen-3.20-dione, Zwischenprodukte und Verfahren zu ihrer Herstellung, 9α -chlor-17α, 21-dihydroxy-1,4-pregnadien-3,20-dion und dieses enthaltende Arzneimittel
US4252729A (en) * 1978-05-12 1981-02-24 Hoffmann-La Roche Inc. Steroids and process for their manufacture
US4252719A (en) * 1978-08-17 1981-02-24 Research Corporation Steroid conversion method and products produced thereby
DE2929558C2 (de) * 1979-07-18 1982-03-11 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑ und/oder Δ↑1↑↑6↑ ungesättigten Steroiden
US4328162A (en) * 1980-09-05 1982-05-04 Eastman Kodak Company Process for preparing 9,11-unsaturated steroidal compound from the corresponding saturated steroidal compound
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
CA3152410A1 (en) 2011-10-14 2013-04-18 Sage Therapeutics, Inc. 3,3-disubstituted 19-nor pregnane compounds, compositions, and uses thereof for the treatment of cns related disorders
CN113527400B (zh) 2013-04-17 2024-06-28 萨奇治疗股份有限公司 19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法
RU2019126333A (ru) 2013-04-17 2019-10-08 Сейдж Терапьютикс, Инк. 19-нор нейроактивные стероиды и способы их применения
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
WO2015010054A2 (en) 2013-07-19 2015-01-22 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2014308621C1 (en) 2013-08-23 2022-01-06 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MX2021004492A (es) 2014-10-16 2022-12-05 Sage Therapeutics Inc Composiciones para el tratamiento de trastornos del snc.
SMT202000414T1 (it) 2014-10-16 2020-09-10 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
ME03749B (me) 2014-11-27 2021-04-20 Sage Therapeutics Inc KOMPOZICIJE I POSTUPCIZA LEČENJE POREMEĆAJA CNS-a
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
EP3280420B1 (en) * 2015-04-10 2024-03-27 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
WO2018013613A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
CA3030420C (en) 2016-07-11 2025-11-18 Sage Therapeutics, Inc. C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE
JP7534291B2 (ja) * 2018-10-19 2024-08-14 セージ セラピューティクス, インコーポレイテッド 9(11)-不飽和神経刺激性ステロイド及びそれらの使用方法
EP3712161A1 (en) * 2019-03-19 2020-09-23 Bionice, S.L.U. Process for preparing high puritiy allopregnanolone and intermediates thereof
CN114206900A (zh) 2019-05-31 2022-03-18 萨奇治疗股份有限公司 神经活性类固醇及其组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2681353A (en) * 1952-03-11 1954-06-15 Sterling Drug Inc Chlorination of keto-steroids
GB1380248A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy steroids and esters thereof

Also Published As

Publication number Publication date
NL7606137A (nl) 1976-12-14
DE2526373C2 (de) 1983-11-10
JPS51149260A (en) 1976-12-22
GB1554901A (en) 1979-10-31
FR2314197A1 (fr) 1977-01-07
DK137837C (da) 1978-10-23
DE2526373A1 (de) 1976-12-30
JPS6146480B2 (OSRAM) 1986-10-14
DD125699A5 (OSRAM) 1977-05-11
DK137837B (da) 1978-05-16
HU174227B (hu) 1979-11-28
CH620452A5 (OSRAM) 1980-11-28
DK260976A (da) 1976-12-12
US4061661A (en) 1977-12-06

Similar Documents

Publication Publication Date Title
FR2327503B1 (OSRAM)
FR2313123B1 (OSRAM)
JPS528725U (OSRAM)
JPS5517220Y2 (OSRAM)
JPS5541165Y2 (OSRAM)
JPS5441900Y1 (OSRAM)
JPS51155713U (OSRAM)
JPS51157632U (OSRAM)
CH605665A5 (OSRAM)
CH599485B5 (OSRAM)
CH575592A5 (OSRAM)
CH600083A5 (OSRAM)
DD125699A5 (OSRAM)
CH592865A5 (OSRAM)
CH597501A5 (OSRAM)
CH606726A5 (OSRAM)
CH600713A5 (OSRAM)
BG21450A1 (OSRAM)
CH593593A5 (OSRAM)
CH603493A5 (OSRAM)
CH599497A5 (OSRAM)
BG21435A1 (OSRAM)
CH602830A5 (OSRAM)
CH602531A5 (OSRAM)
BG21525A1 (OSRAM)

Legal Events

Date Code Title Description
ST Notification of lapse